Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys

Yue Sun, Sampa Santra, Adam P. Buzby, John R. Mascola, Gary J. Nabel, Norman L. Letvin

Research output: Contribution to journalArticle

Abstract

The recently reported modest success of the RV144 Thai trial vaccine regimen in preventing HIV-1 acquisition has focused interest on the potential contribution to that protection of vaccine-elicited CD4+ T cell responses. We evaluated the induction of virus-specific CD4+ T cell responses in rhesus monkeys using a series of diverse vaccine vectors. We assessed both the magnitudes and functional profiles of the antigen-specific CD4+ T cells by measuring cytokine production, memory differentiation, and the expression of mucosal homing molecules. We found that DNA prime/recombinant MVA boost immunizations induced particularly high-frequency virus-specific CD4+ T cell responses with polyfunctional repertoires, and these responses were partially preserved following SHIV-89.6P challenge. The majority of the vaccine-elicited CD4+ T cells were CD28+ memory T cells that expressed low levels of β7. Neither the magnitudes nor the functional profiles of the virus-specific CD4+ T cells generated by vaccination were associated with a preservation of CD4+ T cells or control of viral replication following SHIV-89.6P challenge. Interestingly, monkeys primed with recombinant Ad5 immunogens showed a dramatic expansion of both the magnitude and polyfunctionality of the vaccine-elicited CD4+ T cell responses following envelope protein boost. These results demonstrate that vaccine strategies that include recombinant MVA or recombinant Ad5 vectors can elicit robust CD4+ T cell responses.

Original languageEnglish (US)
Pages (from-to)48-55
Number of pages8
JournalVirology
Volume406
Issue number1
DOIs
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Macaca mulatta
HIV
T-Lymphocytes
Vaccines
Viruses
Virus Activation
CD4 Antigens
Recombinant DNA
Haplorhini
HIV-1
Immunization
Vaccination
Cytokines

Keywords

  • CD4 T cell responses
  • HIV vaccine
  • Rhesus monkey
  • SHIV-89.6P

ASJC Scopus subject areas

  • Virology
  • Medicine(all)

Cite this

Sun, Y., Santra, S., Buzby, A. P., Mascola, J. R., Nabel, G. J., & Letvin, N. L. (2010). Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys. Virology, 406(1), 48-55. https://doi.org/10.1016/j.virol.2010.07.004

Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys. / Sun, Yue; Santra, Sampa; Buzby, Adam P.; Mascola, John R.; Nabel, Gary J.; Letvin, Norman L.

In: Virology, Vol. 406, No. 1, 10.2010, p. 48-55.

Research output: Contribution to journalArticle

Sun, Y, Santra, S, Buzby, AP, Mascola, JR, Nabel, GJ & Letvin, NL 2010, 'Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys', Virology, vol. 406, no. 1, pp. 48-55. https://doi.org/10.1016/j.virol.2010.07.004
Sun, Yue ; Santra, Sampa ; Buzby, Adam P. ; Mascola, John R. ; Nabel, Gary J. ; Letvin, Norman L. / Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys. In: Virology. 2010 ; Vol. 406, No. 1. pp. 48-55.
@article{4a9e9bb7cdb943e296d80c083968889e,
title = "Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys",
abstract = "The recently reported modest success of the RV144 Thai trial vaccine regimen in preventing HIV-1 acquisition has focused interest on the potential contribution to that protection of vaccine-elicited CD4+ T cell responses. We evaluated the induction of virus-specific CD4+ T cell responses in rhesus monkeys using a series of diverse vaccine vectors. We assessed both the magnitudes and functional profiles of the antigen-specific CD4+ T cells by measuring cytokine production, memory differentiation, and the expression of mucosal homing molecules. We found that DNA prime/recombinant MVA boost immunizations induced particularly high-frequency virus-specific CD4+ T cell responses with polyfunctional repertoires, and these responses were partially preserved following SHIV-89.6P challenge. The majority of the vaccine-elicited CD4+ T cells were CD28+ memory T cells that expressed low levels of β7. Neither the magnitudes nor the functional profiles of the virus-specific CD4+ T cells generated by vaccination were associated with a preservation of CD4+ T cells or control of viral replication following SHIV-89.6P challenge. Interestingly, monkeys primed with recombinant Ad5 immunogens showed a dramatic expansion of both the magnitude and polyfunctionality of the vaccine-elicited CD4+ T cell responses following envelope protein boost. These results demonstrate that vaccine strategies that include recombinant MVA or recombinant Ad5 vectors can elicit robust CD4+ T cell responses.",
keywords = "CD4 T cell responses, HIV vaccine, Rhesus monkey, SHIV-89.6P",
author = "Yue Sun and Sampa Santra and Buzby, {Adam P.} and Mascola, {John R.} and Nabel, {Gary J.} and Letvin, {Norman L.}",
year = "2010",
month = "10",
doi = "10.1016/j.virol.2010.07.004",
language = "English (US)",
volume = "406",
pages = "48--55",
journal = "Virology",
issn = "0042-6822",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Recombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys

AU - Sun, Yue

AU - Santra, Sampa

AU - Buzby, Adam P.

AU - Mascola, John R.

AU - Nabel, Gary J.

AU - Letvin, Norman L.

PY - 2010/10

Y1 - 2010/10

N2 - The recently reported modest success of the RV144 Thai trial vaccine regimen in preventing HIV-1 acquisition has focused interest on the potential contribution to that protection of vaccine-elicited CD4+ T cell responses. We evaluated the induction of virus-specific CD4+ T cell responses in rhesus monkeys using a series of diverse vaccine vectors. We assessed both the magnitudes and functional profiles of the antigen-specific CD4+ T cells by measuring cytokine production, memory differentiation, and the expression of mucosal homing molecules. We found that DNA prime/recombinant MVA boost immunizations induced particularly high-frequency virus-specific CD4+ T cell responses with polyfunctional repertoires, and these responses were partially preserved following SHIV-89.6P challenge. The majority of the vaccine-elicited CD4+ T cells were CD28+ memory T cells that expressed low levels of β7. Neither the magnitudes nor the functional profiles of the virus-specific CD4+ T cells generated by vaccination were associated with a preservation of CD4+ T cells or control of viral replication following SHIV-89.6P challenge. Interestingly, monkeys primed with recombinant Ad5 immunogens showed a dramatic expansion of both the magnitude and polyfunctionality of the vaccine-elicited CD4+ T cell responses following envelope protein boost. These results demonstrate that vaccine strategies that include recombinant MVA or recombinant Ad5 vectors can elicit robust CD4+ T cell responses.

AB - The recently reported modest success of the RV144 Thai trial vaccine regimen in preventing HIV-1 acquisition has focused interest on the potential contribution to that protection of vaccine-elicited CD4+ T cell responses. We evaluated the induction of virus-specific CD4+ T cell responses in rhesus monkeys using a series of diverse vaccine vectors. We assessed both the magnitudes and functional profiles of the antigen-specific CD4+ T cells by measuring cytokine production, memory differentiation, and the expression of mucosal homing molecules. We found that DNA prime/recombinant MVA boost immunizations induced particularly high-frequency virus-specific CD4+ T cell responses with polyfunctional repertoires, and these responses were partially preserved following SHIV-89.6P challenge. The majority of the vaccine-elicited CD4+ T cells were CD28+ memory T cells that expressed low levels of β7. Neither the magnitudes nor the functional profiles of the virus-specific CD4+ T cells generated by vaccination were associated with a preservation of CD4+ T cells or control of viral replication following SHIV-89.6P challenge. Interestingly, monkeys primed with recombinant Ad5 immunogens showed a dramatic expansion of both the magnitude and polyfunctionality of the vaccine-elicited CD4+ T cell responses following envelope protein boost. These results demonstrate that vaccine strategies that include recombinant MVA or recombinant Ad5 vectors can elicit robust CD4+ T cell responses.

KW - CD4 T cell responses

KW - HIV vaccine

KW - Rhesus monkey

KW - SHIV-89.6P

UR - http://www.scopus.com/inward/record.url?scp=77956177746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956177746&partnerID=8YFLogxK

U2 - 10.1016/j.virol.2010.07.004

DO - 10.1016/j.virol.2010.07.004

M3 - Article

VL - 406

SP - 48

EP - 55

JO - Virology

JF - Virology

SN - 0042-6822

IS - 1

ER -